-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Praxis Precision Medicine, Maintains $826 Price Target

Benzinga·11/09/2026 17:32:56
Listen to the news
BTIG analyst Kambiz Yazdi reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $826 price target.